Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure.
Journal: JACC. Heart failure
Published: February 16, 2026
Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM.
Journal: Journal of cardiac failure
Published: October 10, 2025
Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.
Journal: Circulation
Published: May 12, 2025
Response to Mavacamten in Patients With High Baseline Left Ventricular Filling Pressures in the EXPLORER-HCM Trial.
Journal: Circulation. Cardiovascular imaging
Published: April 08, 2025
Exposure-Response Modeling and Simulation to Identify Optimal Mavacamten Posology When Coadministered with CYP3A4 and CYP2C19 Inhibitors in Patients with Obstructive HCM.
Journal: Journal of clinical pharmacology
Published: March 25, 2025
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
Journal: Circulation
Published: November 04, 2024
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial.
Journal: Circulation. Cardiovascular imaging
Published: September 02, 2024
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response.
Journal: Journal of the American Heart Association
Published: August 29, 2024
Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM.
Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
Published: June 09, 2024
Association Between age or Duration of Diagnosis in Obstructive Hypertrophic Cardiomyopathy and Response to Mavacamten Treatment: Exploratory Analysis of the EXPLORER-HCM Trial.
Journal: Journal of cardiac failure
Published: June 07, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.
Journal: JACC. Cardiovascular imaging
Published: May 20, 2024
Last Updated: 09/26/2026